TRW & Co · Venture capital
Venture Capital Term Sheets in the UK: Key Terms Explained
A venture capital term sheet UK founders receive summarises the deal: valuation, option pool, liquidation preference, anti-dilution, investor consents, board seats and founder vesting. It is mostly non-binding but sets the frame for the long-form documents. This guide explains each key term under English law and the industry model documents as of October 2026.
Key pointA liquidation preference is generally incompatible with SEIS and EIS, so rounds mixing tax-relief angels and funds usually need two share classes, a point best settled at term sheet stage rather than discovered in the long-form documents.
At a glance
Mostly non-binding
Commercial terms are normally non-binding, but confidentiality, exclusivity, costs and governing law clauses usually bind the company as soon as the term sheet is signed.
Option pool shuffle
Investors often require a new option pool inside the pre-money valuation, which shifts its dilution onto founders and lowers the effective valuation they receive.
1x non-participating preference
The common UK early-stage position lets investors take the higher of their money back or their converted share; participating or multiple preferences are more aggressive.
Weighted average anti-dilution
Broad-based weighted average protection is the usual UK position; a full ratchet resets the investor’s price entirely and can heavily dilute founders in a down round.
Industry model documents
UK Private Capital, formerly the BVCA, publishes model early-stage documents, updated in 2025 to include a summary of terms, AI warranties and sanctions undertakings.
Swipe or scroll →
The short answer: what a venture capital term sheet UK founders sign actually does
A venture capital term sheet UK founders receive is a short summary of the deal: how much the investor will put in, at what valuation, and the rights attached to the new shares. Most of it is not legally binding, but it sets the commercial framework for the long-form subscription agreement, shareholders' agreement and articles of association, and it is very hard to renegotiate later.
The terms that matter most are usually the valuation and option pool, the liquidation preference, anti-dilution protection, investor consent rights, board composition and founder vesting. This guide explains each one under English law, with reference to the industry model documents, as of October 2026.
The legal framework behind UK venture deals
UK venture rounds are documented under English law in most cases, even where investors are overseas. The Companies Act 2006 governs share issues: directors need authority to allot shares under section 551 (or the simpler rule for private companies with one class of shares), statutory pre-emption rights under section 561 must be complied with or disapplied, and changes to the rights of an existing class of shares follow the class rights procedure in section 630 and the articles.
Many UK rounds start from the industry model documents published by UK Private Capital (formerly the BVCA). The suite includes a subscription agreement, disclosure letter, shareholders' agreement, articles and, since its 2025 update, a summary of terms. Using a recognised starting point narrows negotiation, but each investor has its own house positions.
Other regimes can apply. Tax-advantaged investors need the shares to qualify for SEIS or EIS. Investments into businesses in sensitive sectors may require notification under the National Security and Investment Act 2021. Marketing a round to the public engages the financial promotions regime.
Key terms in a venture capital term sheet UK investors issue
Valuation and the option pool
The term sheet states a pre-money valuation, the amount invested and the resulting post-money valuation. The price per share is calculated on a fully diluted basis. The detail that matters is what counts towards the fully diluted share capital. Investors commonly ask for a new or enlarged employee option pool to be created before the round, so its dilution falls on existing shareholders rather than the new investor. Founders should model the effective pre-money valuation once the pool is included.
Liquidation preference
A liquidation preference gives the investor's preferred shares the right to receive their money back, or a multiple of it, before ordinary shareholders on a sale, winding up or other "liquidation event". The common position in UK early-stage deals is a 1x non-participating preference: the investor takes either its money back or its pro rata share as if converted, whichever is higher. Participating preferences, which give both, and multiples above 1x are more investor-friendly and tend to appear in difficult markets or later-stage deals.
Anti-dilution protection
Anti-dilution clauses protect investors if the company later issues shares at a lower price (a "down round"). A broad-based weighted average formula adjusts the investor's position by reference to the size and price of the new issue, and is the usual UK position. A full ratchet resets the investor's price to the new lower price regardless of size, and is much harsher for founders. Check the carve-outs for permitted issues such as employee options.
Investor consents and the board
Investors usually take a list of matters requiring investor consent, such as changing share rights, issuing new shares, borrowing, selling the business, changing the business plan or paying dividends. They also expect a board seat or an observer right and regular information. Founders should keep the list focused on fundamental decisions and make sure consents can be given quickly by an "investor majority" rather than every investor.
Founder vesting, leavers and IP
Investors commonly ask founders to accept reverse vesting, so that a founder who leaves early must sell some of their shares back at a low price. Good leaver and bad leaver definitions decide the price. Founders also give warranties about the business, usually capped at a modest amount, and must confirm that all intellectual property has been assigned to the company. Restrictive covenants usually follow.
Transfers and exits
Standard terms include pre-emption on transfers, drag-along rights that let a majority force a sale, tag-along rights that let minorities join one, and restrictions on founders selling shares. Our guides to shareholder agreements and articles of association explain how these provisions operate.
Look closely at the drag-along threshold. If the investor class alone, or a low overall majority including investors, can force a sale, founders may be dragged into an exit at a price that returns little to ordinary shareholders once the preference is paid. Founders often ask for a minimum price or for founder consent below a certain return.
Other terms you will see
A typical venture capital term sheet UK funds use also covers several shorter points that can still carry real value:
- Pre-emption on new issues. Investors usually take a right to participate in future rounds pro rata, replacing the statutory regime in the articles.
- Dividends. UK early-stage deals rarely include cumulative dividends; a right to share in any dividend paid on ordinary shares is more common.
- Conversion. Preferred shares normally convert into ordinary shares at the holder's option and automatically on an IPO.
- Information rights. Monthly management accounts, an annual budget and audited accounts within a set time.
- Costs. The company usually pays the lead investor's legal fees, often subject to a cap that should be stated.
- Warranties and limitations. The term sheet should set the warranty cap for the company and each founder, and the time limit for claims.
Founder-friendly and investor-friendly terms compared
No venture capital term sheet UK founders receive is purely "standard". The table below shows how the same clause can sit at different points on the spectrum, which helps when deciding where to spend negotiating capital.
| Term | More founder-friendly | More investor-friendly |
|---|---|---|
| Liquidation preference | 1x non-participating | Participating, or a multiple above 1x |
| Anti-dilution | Broad-based weighted average with wide carve-outs | Full ratchet or narrow-based formula |
| Option pool | Sized to the hiring plan, partly post-money | Large pool fully in the pre-money |
| Founder vesting | Credit for time served; acceleration on exit | Full reset; no acceleration |
| Investor consents | Short list, investor majority | Long list, each investor's consent |
| Warranties | Low cap; company-only | Founder warranties with higher caps |
A liquidation preference on preferred shares is generally incompatible with SEIS and EIS, because qualifying shares cannot carry preferential rights to assets on a winding up. If some investors want tax relief, the round is often structured with ordinary shares for SEIS and EIS investors and preferred shares for funds that do not need relief. Settle this in the term sheet.
Before a priced round: convertibles and their effect on the term sheet
Many UK companies raise money before their first priced round using instruments that convert into shares later. The most common are advance subscription agreements, which can be structured to work with SEIS and EIS if HMRC's conditions are met, and convertible loan notes, which are debt until they convert. US-style SAFEs are sometimes used but do not fit as neatly with English company law and the UK tax-advantaged schemes.
These instruments usually convert at a discount to the price in the next round, sometimes with a valuation cap. When a venture capital term sheet UK investors propose arrives, the conversion terms decide how many new shares the earlier investors receive. That dilutes founders and may also dilute the new investor, so the new investor will want the conversion modelled before it agrees the price. Founders should collect all convertible documents, check whether conversion needs further consents and include the converted shares in the pro forma cap table.
Converting investors may also gain rights under the new articles. If the round creates preferred shares, the term sheet should say whether converting investors receive ordinary shares or the new class, which in turn affects SEIS and EIS qualification for any relief-seeking investors among them.
From term sheet to completion
- Negotiate the term sheet. Agree valuation, round size, preference, anti-dilution, consents, board and founder terms. Confirm which parts are binding, typically confidentiality, exclusivity, costs and governing law.
- Exclusivity period. The company usually agrees not to talk to other investors for a set period while the lead investor completes due diligence.
- Due diligence. The investor reviews corporate records, IP ownership, key contracts, employment arrangements and data protection. Our due diligence checklist shows what to prepare.
- Tax clearance where relevant. Apply to HMRC for SEIS or EIS advance assurance if investors need it.
- Long-form documents. Negotiate the subscription agreement, disclosure letter, shareholders' agreement and new articles.
- Corporate approvals. Pass board and shareholder resolutions to adopt the articles, authorise the allotment, disapply pre-emption and approve the option pool. Check any regulatory notification, such as under the NSI Act.
- Completion and filings. Receive funds, issue shares, update the registers and file the allotment return, new articles and resolutions at Companies House within the statutory deadlines.
Illustrative scenario: a seed-to-Series A transition
This scenario is illustrative only; the parties are generic. A London software company raised a seed round from angels under SEIS and EIS. It now receives a Series A term sheet from a fund proposing a 1x participating preference, a full ratchet and a 15% option pool in the pre-money valuation.
The founders push back with market data and agree a 1x non-participating preference, a broad-based weighted average and a smaller pool sized to an 18-month hiring plan. Because the angels need their existing shares to remain qualifying, the fund's preferred shares are a new class, and the existing ordinary shares are not given a preference. The founders also negotiate vesting credit for the two years already worked.
The negotiation took longer than expected, but the outcome shows how each venture capital term sheet UK founders sign can be moved closer to market norms with preparation and clear modelling of the economics.
Risks and common mistakes
Treating the term sheet as non-binding and therefore unimportant
Although most provisions are expressed to be non-binding, the term sheet anchors every later negotiation. Investors will resist reopening points that were agreed in principle, and the binding exclusivity clause removes the company's leverage once signed. Founders should take advice before signing, model the economics at different exit values and make sure any ambiguous term is clarified at this stage rather than in the long-form drafts.
Forgetting existing shareholders' rights
Earlier investors may hold pre-emption rights, consent rights or anti-dilution protection under existing articles and agreements. A new round may need their approval, or trigger adjustments that change the cap table. Some earlier convertible instruments, such as advance subscription agreements, convert on the round and dilute founders further. Review all existing documents and build a pro forma cap table before agreeing the headline valuation.
Losing SEIS or EIS relief by accident
Qualifying shares must be full-risk ordinary shares without preferential rights to assets, and the company must meet the scheme conditions at issue and for three years afterwards. Adding a preference to existing shares, issuing shares to scheme investors with redemption rights, or agreeing protections that reduce risk can cause relief to be withheld or withdrawn. Our guide to SEIS and EIS explains the conditions.
Leaving IP outside the company
Investors will expect all core intellectual property to sit in the company. Code written by founders before incorporation, by contractors or by overseas developers often remains owned by the individual unless it has been assigned in writing. Unassigned IP is a common reason for delays at due diligence. Put assignments in place before the round, using our guide to IP assignment and licensing as a starting point.
Agreeing consent rights that paralyse the business
A long list of investor consents, each needing approval from every investor, can make routine decisions slow. Hiring above a salary level, signing larger customer contracts or opening a bank account should not need investor sign-off. Ask for consent thresholds tied to the approved budget, an investor majority mechanism, deemed consent if investors do not respond within a short period, and a single investor director who can give consent on behalf of the class.
Cross-border angle
US investors often ask UK companies to adopt US-style terms or to "flip" into a Delaware holding company. That can make sense for a US-focused business but has UK tax, SEIS and EIS, and employee option consequences, so it should be planned rather than done at the term sheet stage. Founders from Bangladesh who set up a UK holding company above a Bangladeshi operating business must also consider Bangladeshi foreign investment registration and exchange control on the operating company's side. Our guide on a UK company for Bangladeshi founders covers the structure.
Checklist before you sign
- Build a fully diluted pro forma cap table, including the option pool and any convertibles.
- Model the liquidation preference at low, medium and high exit values.
- Check anti-dilution carve-outs and the consent thresholds.
- Confirm founder vesting, leaver definitions and warranty caps.
- Decide which investors need SEIS or EIS and structure share classes accordingly.
- Check NSI Act exposure if the business operates in a sensitive sector.
TRW & Co's venture capital solicitors in London advise founders and investors on every stage of a funding round, and our share plans and incentives team sets up option pools. If you have received a venture capital term sheet UK investors expect you to sign quickly, contact us at info@trw.co.
Frequently asked questions
01Is a venture capital term sheet legally binding in the UK?
Mostly not. A UK venture term sheet usually states that the commercial terms are subject to contract and due diligence, so neither side is bound to complete the investment on those terms. However, specific clauses are normally expressed to be binding, typically confidentiality, exclusivity, costs and governing law. The exclusivity clause matters most because it prevents the company from negotiating with other investors for a set period. Courts will look at the wording, so make sure the binding and non-binding parts are clearly separated.
02What is a 1x non-participating liquidation preference?
It is a right attached to investors’ preferred shares on a sale, winding up or similar event. The investor receives the higher of its original investment back, or the amount it would receive if its preferred shares converted into ordinary shares. It does not receive both. This is the most common position in UK early-stage rounds. A participating preference, by contrast, gives the investor its money back and then a pro rata share of the remaining proceeds, which can significantly reduce founders’ returns at modest exit values.
03How does anti-dilution protection work?
Anti-dilution protection compensates investors if the company later issues shares at a lower price than they paid. It usually works by issuing additional shares to the protected investor, often for nominal consideration, so that its average price is adjusted downwards. A broad-based weighted average formula takes account of how many new shares are issued and at what price, so a small down round has a limited effect. A full ratchet adjusts to the new price however few shares are issued and is much harsher.
04Can investors with a liquidation preference claim EIS relief?
Generally not on those shares. To qualify for SEIS or EIS, shares must be full-risk ordinary shares that are not redeemable and carry no preferential rights to the company’s assets on a winding up, although limited non-cumulative preferential dividend rights are allowed. A liquidation preference is a preferential right to assets. Rounds that include tax-relief investors and institutional funds therefore usually issue ordinary shares to the former and preferred shares to the latter. HMRC advance assurance can confirm the analysis before shares are issued.
05What is founder reverse vesting?
Reverse vesting means founders keep their existing shares, but agree that if they leave within a set period, some or all of their shares can be compulsorily transferred at a low price. The proportion that is subject to transfer reduces over time. Investors use it to make sure departing founders do not keep a large stake in a company they no longer build. Founders should negotiate credit for time already served, acceleration on a sale, and fair good leaver definitions. Tax elections may also be needed.
06Do I need a lawyer to review a term sheet?
It is strongly advisable. The term sheet sets the economics and control terms that will appear in the long-form documents, and once exclusivity is signed the company has less leverage. A lawyer can explain how the liquidation preference, anti-dilution and option pool interact with the cap table, identify unusual investor protections, check consistency with existing shareholder rights and flag tax and regulatory issues such as SEIS, EIS or the National Security and Investment Act. Early advice usually reduces cost later in the process.
Sources and official materials
- UK Private Capital: Model Documents for Early Stage Investments — Industry model term sheet, subscription agreement, SHA and articles
- Companies Act 2006, section 551 — Directors’ authority to allot shares
- Companies Act 2006, section 561 — Statutory pre-emption rights on allotment
- Companies Act 2006, section 630 — Variation of class rights
- GOV.UK: National Security and Investment Act — Notification requirements for sensitive-sector investments
- HMRC: Apply to use the Enterprise Investment Scheme — Share requirements and conditions for EIS
General information only, current as at 21 October 2026. It is not legal advice and does not create a solicitor–client relationship. It reflects the law of England and Wales unless stated otherwise; Scotland and Northern Ireland have separate legal systems, and the law changes frequently. Check current official sources and take advice on the facts of your matter.